Management of asthmatic patients with COVID-19
| Management | |
| Oxygen | 30 (81) |
| Antibiotic(s) | 31 (84) |
| Azithromycin | 16 (52) |
| IV or oral CS for asthma exacerbation during hospitalisation | 1 (3) |
| SABA prescription | 31/36 (86) |
| pMDI+spacer chamber | 29/31 (94) |
| DPI | 2/31 (6) |
| Nebulized | 4/31 (13) |
| Asthma controller treatment adjustment | |
| Maintenance | 33/35 (94) |
| Stepped-up | 1/35 (3) |
Quantitative data are expressed as median (IQR). IQR is presented as first quartile (Q1) – third quartile (Q3). Qualitative data are expressed as number of occurrences, n (% of total). In case of variable with missing data, the number of patients with available information is specified.